September 6, 2023:

The Big Ten Cancer Research Consortium’s annual summit is being held at Big Ten Conference Headquarters in Chicago. The summit will take place on Saturday, September 30, 2023, and is hosted by the University of Wisconsin Carbone Cancer Center.

This meeting will bring together members from Big Ten Cancer Research Consortium institutions, industry and patient advocates to strengthen our collaboration and explore opportunities for novel therapeutic advances in clinical oncology.

The packed agenda includes presentations from investigators of Big Ten CRC trials, cancer center leadership speaking on the 10-year anniversary of the Big Ten CRC, and an opportunity for investigators to connect with industry partners through pipeline presentations.

Additionally, attendees will have the opportunity to hear about the Big Ten CRC’s newest diversity initiatives and updates from our Population Science and Adolescent/Young Adult clinical trial working groups.

This is a great opportunity for senior and junior faculty and fellows involved in clinical oncology research, basic scientists involved in drug discovery and translational research, cancer center leadership and administration, industry leaders and medical science liaisons, and patient advocates.

Thank you to the University of Wisconsin Carbone Cancer Center, for hosting the Big Ten CRC Summit!

The University of Wisconsin Carbone Cancer Center became one of the first six comprehensive cancer centers designated by the National Cancer Institute in 1973. UW Carbone is an integral part of the UW School of Medicine and Public Health and UW Health and brings together more than 330 physicians and scientists from 50 departments and nine schools across the University of Wisconsin-Madison campus to conduct research and translate laboratory discoveries into new patient treatments.

About the Big Ten Cancer Research Consortium: The Big Ten cancer centers have united to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team-research culture to drive science rapidly from ideas to treatment-changing paradigms. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 14 Big Ten institutions will provide over $200 million in direct financial support to more than 9,800 students for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women, including the addition of men’s ice hockey and men’s and women’s lacrosse since 2013. For more information, visit